bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Centessa Pharmaceuticals logo

    Centessa Pharmaceuticals

    CNTA | NASDAQ
    Chart Builder DCF Calculator
    $40.50
    $0 (0.00%)
    At close: Jun 25, 2026, 4:00 PM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $6.27B
    Enterprise Value
    $6B
    Beta
    1.12
    Average Volume
    2.59M
    Shares Outstanding (Diluted)
    153.55M
    Shares Change YoY
    15.42%
    Institutional Ownership
    N/A
    Exchange
    NASDAQ
    ISIN
    US1523091007

    Price Performance

    Price Change 1M
    1.8%
    Price Change 3M
    2.0%
    Price Change 6M
    61.9%
    Price Change YTD
    71.0%
    Price Change 1Y
    208.2%
    Price Change 3Y
    554.3%
    Price Change 5Y
    83.1%
    1M CAGR (ann.)
    2.3%
    1Y CAGR (ann.)
    210.6%
    5Y CAGR (ann.)
    10.3%
    All-Time CAGR
    13.0%

    Valuation

    PE Ratio
    -22.75
    Forward PE
    N/A
    PEG Ratio
    3.15
    Forward PEG
    -5.69
    PS Ratio
    N/A
    Forward PS
    250.70
    PB Ratio
    12.86
    P/FCF Ratio
    -29.96
    P/Adj. FCF Ratio
    -25.81
    P/OCF Ratio
    -29.78
    EV/Sales
    N/A
    EV/EBIT
    -22.59
    EV/EBITDA
    -22.56
    EV/FCF
    -28.67
    Earnings Yield
    -4.4%
    FCF Yield
    -3.3%
    Adj. FCF Yield
    -3.9%

    Financial Health

    Net Cash
    $269.22M
    Total Debt
    $7.37M
    Cash & Short-Term Investments
    $276.59M
    Total Assets
    $641.76M
    Current Ratio
    9.53
    Quick Ratio
    9.53
    Debt / Equity Ratio
    0.02
    Debt / EBITDA
    -0.03
    Debt / FCF
    -0.04
    OCF / Debt
    -28.32
    Interest Coverage
    -22.70
    Altman Z-Score
    20.81
    Piotroski F-Score
    3

    Margins & Profitability

    Gross Profit Margin
    0.0%
    Operating Profit Margin
    0.0%
    EBITDA Margin
    0.0%
    Net Profit Margin
    0.0%
    FCF Margin
    N/A
    Adj. FCF Margin
    N/A
    SBC / Revenue
    0.0%
    SBC Impact (per share)
    -16.1%

    Returns

    Return on Assets
    -39.0%
    Return on Equity
    -60.4%
    Return on Invested Capital
    -42.4%
    Return on Capital Employed
    -42.4%
    Return on Tangible Assets
    -39.0%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    -47.0%
    Revenue CAGR 5Y
    34.3%
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    -10.8%
    EPS CAGR 5Y
    8.5%
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    -17.1%
    FCF CAGR 5Y
    -1.9%
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    14
    EPS Growth Next 3Y
    48.5%
    Revenue Growth Next 3Y
    N/A
    Earnings Date
    Aug 10, 2026
    EPS Estimate (next Q)
    -$0.40
    EPS Growth Est (next Q)
    5.3%
    Revenue Est (next Q)
    N/A
    Revenue Growth Est (next Q)
    N/A

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $42
    Price Target Upside
    3.7%

    Cash Flow

    Operating Cash Flow
    $-208.8M
    Free Cash Flow
    $-209.17M
    Adj. Free Cash Flow
    $-242.81M
    FCF Per Share
    -$1.36
    OCF Per Share
    -$1.36
    OCF/S Ratio
    0.0%

    Income Statement

    Revenue
    $0
    Gross Profit
    $-238.6K
    Operating Income
    $-256.69M
    EBITDA
    $-265.82M
    Net Income
    $-250.64M
    EPS (Diluted)
    -$1.78
    Revenue / Employee
    N/A
    Profit / Employee
    $-3.26M
    Employees
    77

    © 2026 bestshares.com. All rights reserved.